股本结构
单位:万股
公告日期 | 2024-05-15 | 2024-04-19 | 2024-03-18 | 2024-04-19 | 2023-12-21 | 2023-12-06 |
---|---|---|---|---|---|---|
证券总股本 | 559.56 | 438.50 | 424.95 | 297.39 | 261.95 | 95.13 |
普通股本 | 223822.57 | 175399.85 | 169980.41 | 118957.77 | 104780.65 | 38050.17 |
优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
变动日期 | 2024-05-15 | 2024-04-01 | 2024-03-01 | 2023-12-31 | 2023-12-21 | 2023-12-01 |
注释:中概股证券总股本=普通股股本/
存托凭证比例
,当前存托凭证比例为:400
历史变动
公告日期 | 变动后普通股本(万股) | 变动后优先股(万股) | 变动原因 | 变动日期 |
---|---|---|---|---|
2024-05-15 | 223822.57 | 未披露 | 定期报告 | 2024-05-15 |
2024-04-19 | 175399.85 | 未披露 | 定期报告 | 2024-04-01 |
2024-03-18 | 169980.41 | 未披露 | 定期报告 | 2024-03-01 |
2024-04-19 | 118957.77 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Private Placements
Registered Direct Offering
Shares issued on purchase Intangible asset
Registered Offering
|
2023-12-31 |
2023-12-21 | 104780.65 | 未披露 |
更多>>
Class A Units offered 697,614,represents 279,045,600 Ordinary shares by the company
|
2023-12-21 |
2023-12-06 | 38050.17 | 未披露 | 定期报告 | 2023-12-01 |
2023-10-06 | 36579.97 | 未披露 | 定期报告 | 2023-08-31 |
2023-11-28 | 27797.17 | 未披露 | 定期报告 | 2023-06-30 |
2023-06-16 | 21385.90 | 未披露 | 定期报告 | 2023-06-12 |
2023-05-25 | 20735.90 | 未披露 |
更多>>
Registered Depositary Shares offered by the company 110,679,610 Shares
|
2023-05-26 |
2023-05-25 | 9667.94 | 未披露 | 定期报告 | 2023-05-19 |
2023-04-19 | 9462.94 | 未披露 |
更多>>
The Company's enlarged issued share capital on Admission will comprise 94,629,412 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 25 April 2023, this figure of 94,629,412 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
|
2023-04-25 |
2023-04-12 | 8835.39 | 未披露 |
更多>>
The Company's enlarged issued share capital on Admission will comprise 88,353,947 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 17 April 2023, this figure of 88,353,947 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
|
2023-04-17 |
2023-04-07 | 7735.27 | 未披露 |
更多>>
The Company's enlarged issued share capital on Admission will comprise 77,352,692 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 14 April 2023, this figure of 77,352,692 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
|
2023-04-14 |
2023-04-05 | 7305.89 | 未披露 |
更多>>
The Company's enlarged issued share capital on Admission will comprise 73,058,872 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 13 April 2023, this figure of 73,058,872 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
|
2023-04-13 |
2023-03-24 | 866.73 | 未披露 |
更多>>
The Share Consolidation consists of a consolidation of the ordinary shares of £0.001 each in the capital of the Company (the “Ordinary Shares”), such that every 20 Ordinary Shares will be consolidated into one new ordinary share of £0.02 nominal value each (the “Consolidated Ordinary Shares”).
|
2023-03-27 |
2023-03-08 | 17334.67 | 未披露 | 定期报告 | 2023-03-01 |
2022-12-16 | 10834.27 | 未披露 |
更多>>
Registered Depositary Shares offered 393,973 shares by the company,each representing 25 ordinary shares
|
2022-12-15 |
2022-10-18 | 9849.34 | 未披露 | 定期报告 | 2022-10-14 |
2022-04-26 | 9846.84 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Shares issued on 6 July 2021
|
2021-12-31 |
2021-04-30 | 6338.07 | 未披露 | 定期报告 | 2021-04-15 |
2021-04-30 | 6307.39 | 未披露 |
更多>>
From January 1, 2020 to December 31, 2020
Shares issued on 18 May 20206
Shares issued on 27 July 2020
Shares issued on 19 August 2020
|
2020-12-31 |
2020-08-05 | 6054.89 | 未披露 | 定期报告 | 2020-07-31 |
2020-06-15 | 3925.26 | 未披露 | 定期报告 | 2020-05-22 |
2020-03-02 | 2349.50 | 未披露 |
更多>>
Consequently, with effect from tomorrow, 3 March 2020, Midatech’s existing ordinary shares of 0.005p each in the capital of the Company (“Existing Ordinary Shares”) will be consolidated on a one for 20 basis into new ordinary shares of 0.1p each in the capital of the Company (“New Ordinary Shares”).
|
2020-03-03 |
2020-06-15 | 46989.96 | 未披露 |
更多>>
From January 1, 2019 to December 31, 2019
Shares issued
|
2019-12-31 |
2019-10-25 | 46989.96 | 未披露 | 定期报告 | 2019-10-25 |
2019-10-11 | 40989.96 | 未披露 | 定期报告 | 2019-10-10 |
2019-09-30 | 40939.96 | 未披露 |
更多>>
from January 1, 2019 to June 30, 2019
Subscription Placing and Open Offer
|
2019-06-30 |
2019-04-30 | 40939.96 | 未披露 |
更多>>
On 26 February 2019, as a result of a Subscription, Placing and Open Offer, 348,215,478 new ordinary shares were issued, increasing the total number of issued shares to 409,399,613.
|
2019-04-15 |
2019-04-24 | 6118.41 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Share issue to SIPP trustee
|
2018-12-31 |
2018-04-23 | 6108.41 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Share issue to SIPP trustee
Placing and Open Offer
Share issue to SIPP trustee
|
2017-12-31 |
2017-09-28 | 4871.95 | 未披露 |
更多>>
from January 1, 2017 to June 30, 2017
Issue of shares to Employee Share Incentive Plan
|
2017-06-30 |
2017-04-06 | 4869.95 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Deferred consideration re: acquisition of Q Chip Limited
Placing and Open Offer
|
2016-12-31 |
2016-09-02 | 3354.24 | 未披露 | 定期报告 | 2016-06-30 |
2016-04-14 | 3346.75 | 未披露 |
更多>>
from January 1 , 2015 to December 31, 2015
Exercise of employee share options
Share issue on acquisition of DARA BioSciences, Inc.
Deferred consideration re: acquisition of QChip Limited
|
2015-12-31 |
2015-12-30 | 3346.75 | 未披露 | 定期报告 | 2015-12-30 |
2015-10-09 | 2782.08 | 未披露 | 定期报告 | 2015-10-02 |
From December 31,2022 to December 31,2023
Private Placements
Registered Direct Offering
Shares issued on purchase Intangible asset
Registered Offering
Class A Units offered 697,614,represents 279,045,600 Ordinary shares by the company
Registered Depositary Shares offered by the company 110,679,610 Shares
The Company's enlarged issued share capital on Admission will comprise 94,629,412 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 25 April 2023, this figure of 94,629,412 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
The Company's enlarged issued share capital on Admission will comprise 88,353,947 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 17 April 2023, this figure of 88,353,947 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
The Company's enlarged issued share capital on Admission will comprise 77,352,692 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 14 April 2023, this figure of 77,352,692 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
The Company's enlarged issued share capital on Admission will comprise 73,058,872 ordinary shares, each with voting rights. The Company does not hold any shares in treasury. From Admission, expected to take place on 13 April 2023, this figure of 73,058,872 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules.
The Share Consolidation consists of a consolidation of the ordinary shares of £0.001 each in the capital of the Company (the “Ordinary Shares”), such that every 20 Ordinary Shares will be consolidated into one new ordinary share of £0.02 nominal value each (the “Consolidated Ordinary Shares”).
Registered Depositary Shares offered 393,973 shares by the company,each representing 25 ordinary shares
From January 1, 2021 to December 31, 2021
Shares issued on 6 July 2021
From January 1, 2020 to December 31, 2020
Shares issued on 18 May 20206
Shares issued on 27 July 2020
Shares issued on 19 August 2020
Consequently, with effect from tomorrow, 3 March 2020, Midatech’s existing ordinary shares of 0.005p each in the capital of the Company (“Existing Ordinary Shares”) will be consolidated on a one for 20 basis into new ordinary shares of 0.1p each in the capital of the Company (“New Ordinary Shares”).
From January 1, 2019 to December 31, 2019
Shares issued
from January 1, 2019 to June 30, 2019
Subscription Placing and Open Offer
On 26 February 2019, as a result of a Subscription, Placing and Open Offer, 348,215,478 new ordinary shares were issued, increasing the total number of issued shares to 409,399,613.
from December 31, 2017 to December 31, 2018
Share issue to SIPP trustee
from December 31, 2016 to December 31, 2017
Share issue to SIPP trustee
Placing and Open Offer
Share issue to SIPP trustee
from January 1, 2017 to June 30, 2017
Issue of shares to Employee Share Incentive Plan
from December 31, 2015 to December 31, 2016
Deferred consideration re: acquisition of Q Chip Limited
Placing and Open Offer
from January 1 , 2015 to December 31, 2015
Exercise of employee share options
Share issue on acquisition of DARA BioSciences, Inc.
Deferred consideration re: acquisition of QChip Limited